Phase II/III (Integrated)

392 trials 186 recruiting

Filter these 392 trials by condition, country, sponsor and more.

Open in Search →

Long Term Follow-up Study of AAVAnc80-hOTOF Gene Therapy Recruiting

2024-512584-31-00 Otoferlin gene-mediated hearing loss 2024-11-11
A Phase II randomized trial of RSV vaccination in allogeneic hematopoietic stem cell transplant recipients (RSV-Allo study) Recruiting

2024-513290-53-00 allogeneic - Hematopoietic Stem Cell Transplantation 2024-11-07
Efficacy and Safety of Obinutuzumab versus Rituximab in childhood Steroid Dependant and Frequent Relapsing Nephrotic Syndrome : à double-bli… Recruiting

2024-514240-93-00 Idiopathic nephrotic syndrome (INS) 2024-10-31
Study of the efficacy and safety of etanercept treatment in patients with SAPHO syndrome Recruiting

2024-516919-25-00 SAPHO syndrome (synovitis, acne, pustulosis, hyperostos 2024-10-22
Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1 Recruiting

2023-509428-16-00 HIV-1 Infection 2024-10-15
TAP-TAU Recruiting

2023-505430-10-00 Mild cognitive impairment and dementia 2024-10-10
IDE196 (Darovasertib) in Combination with Crizotinib as First-line Therapy in Metastatic Uveal Melanoma Recruiting

2023-506686-66-01 HLA-A2 negative metastatic uveal melanoma 2024-10-09
Efficacy of endothelin receptor antagonism in treatment of coronary artery spasm: a randomized controlled clinical trial. (EDIT-CAS) Recruiting

2023-507782-25-00 Coronary vasomotor dysfunction (spasm) 2024-09-27
A Phase 2/3 study to evaluate safety and efficacy of the combination of Bel- CHOP/ Fol-COP drugs against CHOP in newly diagnosed Peripheral … Recruiting

2023-507803-76-00 Peripheral T-Cell Lymphoma 2024-09-26
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy Recruiting

2023-508811-21-00 Refractory Focal Onset Epilepsy 2024-09-25
EEG-MRI Study of the Effect of Methylphenidate on Neural Mechanisms in Adult Patients With ADHD With or Without Mood Disorders: a Randomized… Recruiting

2024-516902-46-00 Attention Deficit Hyperactivity Disorder (ADHD) 2024-09-19
A trial to evaluate the efficacy and safety of oral controlled-ileocolonic-release nicotinamide (CICR-NAM) in patients with mild to moderate… Recruiting

2024-510807-13-00 ulcerative colitis 2024-09-12
A study of efgartigimod PH20 SC in children between 2 and less than 18 years of age with generalized myasthenia gravis Recruiting

2023-506159-12-00 Generalized Myasthenia Gravis 2024-09-06
Evaluating the Diagnostic Performance of Human Epidermal Growth Factor Receptor 2 (HER2) targeted Positron Emission Tomography and Computed … Recruiting

2024-511419-22-00 Hormone receptor positive/HER2 negative, triple-negativ 2024-09-03
DICIT: Efficacy of diclofenac added to an approved, ongoing PD-1 inhibitor therapy that achieved stable disease as best response in metastat… Recruiting

2023-504191-26-00 Metastatic Melanoma 2024-08-23
A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Subjects With Generalized Myasthenia Gravis Recruiting

2023-509892-17-00 Generalized myasthenia gravis 2024-07-09
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High Grade Ovarian, Primary Peritoneal, or Fallopian Tube Can… Recruiting

2023-507914-28-00 Platinum-resistant, high-grade serous ovarian cancer (O 2024-06-19
A study to learn if rozanolixizumab is safe, how it moves through the body, and if it works in children with myasthenia gravis Recruiting

2022-502074-16-00 Generalized Myasthenia Gravis 2024-06-14
Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamo… Recruiting

2023-506308-24-00 Recurrent or metastatic head and neck squamous cell car 2024-05-22
A study of the efficacy and safety of belimumab compared to placebo in adults with systemic sclerosis-associated interstitial lung disease. Recruiting

2023-503219-14-01 systemic sclerosis associated interstitial lung disease 2024-05-22
A Phase 2/3 trial to investigate visualization of the ureters with nizaracianine triflutate, intravenous, in participants aged 18 years or o… Recruiting

2023-503241-63-00 Urinary tract imaging 2024-05-21
An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study with Open-Label Extension Evalu… Recruiting

2023-508818-42-00 Generalized Epidermolysis Bullosa Simplex (EBS) 2024-05-21
Locally Advanced or Metastatic Hepatocellular Carcinoma: Dose Optimization, Safety, and Efficacy of Livmoniplimab in Combination with Budiga… Recruiting

2023-504600-28-00 Metastatic Hepatocellular Carcinoma (HCC) 2024-05-09
Long-Term Follow-Up of Subjects Treated With NTLA-2001 Recruiting

2023-507385-11-00 -Hereditary Transthyretin Amyloidosis with Polyneuropat 2024-05-06